Clinical Trials

Showing trials with last updates posted in 2025.

NCT05417386 | TERMINATED | PHASE1
4 participants

FOLFIRINOX + NIS793 in Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-18
Start Date:
2022-08-09
Completion:
2023-07-10
Conditions
  • Pancreas Cancer
  • Metastatic Pancreatic Cancer
  • Metastatic Pancreatic Adenocarcinoma
Interventions
  • DRUG
  • RADIATION
  • PROCEDURE
No Results Yet
NCT04828486 | COMPLETED | PHASE2
14 participants

Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-18
Start Date:
2021-08-17
Completion:
2024-09-18
Conditions
  • Advanced Hepatocellular Carcinoma
  • BCLC Stage A Hepatocellular Carcinoma
  • BCLC Stage B Hepatocellular Carcinoma
  • BCLC Stage C Hepatocellular Carcinoma
  • Metastatic Hepatocellular Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
NCT04745637 | AVAILABLE

Managed Access Programs for INC424, Ruxolitinib

Study Type:
EXPANDED_ACCESS
Last Updated:
2025-11-18
Conditions
  • Primary Myelofibrosis (PMF)
  • Post Polycythemia Myelofibrosis (PPV MF)
  • Thrombocythemia Myelofibrosis (PET-MF)
  • Severe/Very Severe COVID-19 Illness
  • Polycythemia Vera (PV)
  • Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD)
  • Steroid Refractory Chronic Graft Versus Host Disease (SR cGVHD)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page